Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Nu-Med Plus (NUMD) Debt to Equity (2017 - 2021)

Nu-Med Plus' Debt to Equity history spans 7 years, with the latest figure at $0.05 for Q1 2021.

  • Quarterly results put Debt to Equity at $0.05 for Q1 2021, up 115.27% from a year ago — trailing twelve months through Mar 2021 was $0.05 (up 115.27% YoY), and the annual figure for FY2020 was $0.02, up 106.51%.
  • Debt to Equity for Q1 2021 was $0.05 at Nu-Med Plus, up from $0.02 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.57 in Q3 2020 to a low of -$0.85 in Q1 2018.
  • The 5-year median for Debt to Equity is $0.01 (2020), against an average of -$0.01.
  • Peak annual rise in Debt to Equity hit 5945.11% in 2020, while the deepest fall reached 759.29% in 2020.
  • Year by year, Debt to Equity stood at $0.29 in 2017, then surged by 54.38% to $0.45 in 2018, then plummeted by 168.27% to -$0.31 in 2019, then skyrocketed by 106.51% to $0.02 in 2020, then soared by 144.93% to $0.05 in 2021.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.05, $0.02, and $0.57 for Q1 2021, Q4 2020, and Q3 2020 respectively.